Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 41Specimen Handling 36Carboplatin 34pembrolizumab 32Bevacizumab 32Magnetic Resonance Spectroscopy 29olaparib 19liposomal doxorubicin 16Cisplatin 16Biopsy 16Gemcitabine 15Taxes 12Nivolumab 12Immunoglobulin G 11Disulfides 11Cyclophosphamide 11Topotecan 10Doxorubicin 10fludarabine 9niraparib 7mirvetuximab soravtansine 7Fulvestrant 7trastuzumab deruxtecan 6palbociclib 6durvalumab 6Surveys and Questionnaires 6Megestrol Acetate 6lenvatinib 5dostarlimab 5Radiation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Papanicolaou Test × Gynecologic × 30 days × Clear all
NCT07214506 2026-05-29

HOPE

University of Arizona

Phase NA Not yet recruiting
100 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05049538 2026-05-06

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

M.D. Anderson Cancer Center

Recruiting
1,000 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡